GlassScriptPhysician profile
Jason D Cohen
NPI 1417934449
$4,744.04
in general payments reported to CMS, 2019-2025
15 companies · $517 in 2025
The $517 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,661 · 2020: $475 · 2021: $969 · 2022: $648 · 2023: $167 · 2024: $308 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,390.96 | 2019-2022 | |
| Globus Medical, INC. | $1,280.69 | 2019 | |
| Alphatec Spine, INC | $840.87 | 2019-2025 | Other - Miscellaneous, Invictus Open, Lif |
| Augmedics INC. | $269.06 | 2020-2021 | |
| Seaspine Orthopedics Corporation | $257.86 | 2020-2022 | |
| Depuy Synthes Sales INC. | $230.96 | 2020-2023 | Lcp, Teligen |
| Abbott Laboratories | $132.11 | 2021 | |
| Heron Therapeutics, INC. | $125.00 | 2021 | |
| Orthofix Medical, INC. | $113.22 | 2023-2024 | Admiral |
| Smith+Nephew, INC. | $28.94 | 2024 | Real Intelligence |
| Integrity Implants INC. | $22.34 | 2022 | |
| Intrinsic Therapeutics | $21.86 | 2025 | Barricaid Acd (Annular Closure Device) |
| Biotronik Nro, INC. | $21.23 | 2025 | Prospera |
| Spinal Elements, INC. | $5.20 | 2024 | |
| Biocomposites INC | $3.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.